Introduction {#s1}
============

Elevated resting heart rate has been shown to be associated with mortality across several general population studies[@R1; @R2; @R3] and in patient populations.[@R4] [@R5]

In healthy subjects, the main question is whether a high resting heart rate is an independent risk factor, a surrogate marker of subclinical disease states, or a marker of poor physical fitness. A number of studies have shown that resting heart rate is associated with circulating levels of inflammatory markers related to subclinical chronic disease states.[@R6; @R7; @R8] Resting heart rate is determined by the activity of the autonomic nervous system, levels of circulating hormones and cardiorespiratory fitness.[@R9] [@R10] The association between a high level of cardiorespiratory fitness (physical fitness) and a low resting heart rate is well known[@R11] and physical fitness may therefore be an important confounding factor. Most general population studies have included information about self-reported physical activity.[@R12] [@R13] However, the correlation between self-reported physical activity and objectively measured physical fitness is only poor to moderate.[@R14] The lack of objectively measured physical fitness in the current literature may have resulted in residual confounding and may have influenced the interpretation of previous findings.

In the present study, we investigated whether resting heart rate was predictive of mortality in a population of employed apparently healthy middle-aged men who previously had physical fitness determined by a bicycle ergometer test and were followed for 16 years.

Methods {#s2}
=======

Population {#s2a}
----------

The Copenhagen Male Study was set up in 1970--1971 as a prospective cardiovascular study of Caucasian middle-aged men employed at 14 large workplaces in Copenhagen.[@R15] [@R16]

### First examination, 1970--1971 {#s2a1}

Overall, 6125 men were invited to participate; 5249 men (87%) agreed. All men were interviewed by a physician (FG) about a previously completed questionnaire, and had a clinical examination including measurement of physical fitness (VO~2~Max) using a bicycle ergometer.

Physical fitness was determined using a bicycle ergometer and Åstrand nomogram and estimated through information on heart rate and workload. Heart rate was measured during submaximal bicycle work in a steady state with the aid of a stopwatch and a stethoscope. The loads used were 100, 150 and 200 W. One, two, or in a few cases three different loads were used. The load chosen in each case was determined from the weight and age of the person or heart rate during the first minute of the test. The method used has previously been described in detail.[@R15]

### Second examination, 1985--1986 {#s2a2}

In 1985--1986 a new baseline was established, which was used for the analyses in the present study together with information on VO~2~Max measured in 1970--1971. All survivors from the 1970--1971 examination were traced through the Danish National Civil Registry. Between June 1985 and June 1986, 4505 men, except 34 subjects who emigrated and therefore were lost to follow-up, were invited to take part in this new study; 3387 men (75%) agreed to participate and gave informed consent. Their mean age was 63 years (range 53--75). We excluded 33 invalid questionnaires, leaving 3354 men for the analysis; within this group 319 men were excluded because of cardiovascular disease (angina pectoris, acute myocardial infarction, stroke and/or intermittent claudication); a further 34 men without sinus rhythm on ECG were excluded, as were 85 men with diabetes or glucosuria; in all, 2798 men with useful information on heart rate from ECG and measurement of VO~2~Max from the first baseline in 1970--1971 were included ([figure 1](#HEARTJNL2012303375F1){ref-type="fig"}). At baseline in 1970--1971, the 1985--1986 non-responders were more likely to be older, smokers, have higher alcohol consumption and higher blood pressure (BP) than the responders. However, the difference in mean levels of physical fitness was small (32.1 vs 32.7 ml/kg/min).

![Flow-chart for the Copenhagen Male Study.](heartjnl-2012-303375f01){#HEARTJNL2012303375F1}

All men were interviewed by a physician (HOH) about a previously completed questionnaire, and were examined with measurements of height, body weight, and BP; a fasting venous blood sample was taken for the determination of serum lipids, and a urine sample for determination of glucosuria.

A resting ECG was recorded at the 1985--1986 examination, using a three channel Mingograph-34 by taking 12 standard leads in a supine position. A skilled technician coded according to the Minnesota code. As mentioned, only subjects with sinus rhythm were included in the study.

Medical history, smoking habits, alcohol consumption and leisure-time physical activity were assessed from the questionnaire. The men classified themselves as never having smoked, being a previous smoker or being a current smoker. Current tobacco smoking was calculated from information about the number of cigarettes, cheroots or cigars, or the weight of pipe tobacco smoked daily. One cigarette was taken as equivalent to 1 g of tobacco, one cheroot as 3 g and one cigar as 4 g. As previously estimated by means of measurements of serum cotinine, the validity of tobacco reporting was high.[@R17] Cumulative tobacco consumption (in pack-years) was calculated on the basis of information about mean total daily use of tobacco in grams multiplied by the time as a smoker in years divided by 20. In the multivariable analyses, cumulative tobacco consumption was included as a predictor/confounder.

The men were subdivided into five social classes, using a modification of a system by Svalastoga[@R18] based on the level of education and the job profile. Men in social class I were predominantly academics and well skilled administrators or executives; men in social class V were unskilled and semiskilled workers.

Body mass index (BMI) was calculated as weight in kg divided by height in m^2^. Serum concentrations of total cholesterol, high density lipoprotein cholesterol (HDL-C) and triglycerides (TGs) were determined using enzymatic assays (Boehringer-Mannheim Biochemica, Mannheim, Germany).[@R19] Fasting lipids were measured only once in each subject. Definitions of high serum TG (≥1.70 mmol/l), low HDL-C (≤1.03 mmol/l), high systolic BP (\>130 mm Hg) and high diastolic BP (\>85 mm Hg) were based on criteria for definition of the metabolic syndrome according to the Adult Treatment Panel III.[@R20] Low density lipoprotein cholesterol (LDL-C) was calculated using the indirect method as developed by Friedewald.[@R21] Urine samples were examined for glucosuria using a glucose kinase method (Clinistix, Bayer, Leverkusen, Germany).

BP was measured on the right arm with the subject seated and after at least 10 min of rest, using a manometer developed by the London School of Hygiene and Tropical Medicine. Information on hypertension treatment was obtained from the questionnaire.

Ethics approval from the regional ethics committee was obtained for the second examination in 1985--1986; no approval was possible for the 1970--1971 examination since the ethics committee did not exist before 1980.

### Follow-up, 2001 {#s2a3}

Information about vital status as of 31 December 2001 was collected through national registers for all subjects who had participated in both the 1970 examination and the 1985--1986 examination.

Statistical analyses {#s2b}
--------------------

Basic statistical analyses, including trend tests, Kendall\'s τ B and test for linearity in analysis of variance, and regression analyses were performed. The population was divided into categories of resting heart rate. Relative risks were estimated by exp(β), where β is the hazard coefficient for the variable of interest in a Cox proportional hazards regression model, using the maximum likelihood ratio method and a backward stepwise elimination procedure.[@R22] Assumptions regarding the use of Cox proportional hazards were met by inspection of the log minus log function at the covariate mean.

First, we studied the correlation between physical fitness measured at the first examination and level of resting heart rate measured at the second examination. Second, we studied the relationship between resting heart rate and mortality in Cox models adjusting for: (1) age alone; (2) age and physical fitness (VO~2~Max); (3) age, leisure-time physical activity, tobacco consumption and alcohol intake; (4) age, BMI, systolic and diastolic BP, serum TGs and serum total cholesterol; and (5) in a fully adjusted model including all potential confounders from analyses 1--4. Also, based on findings from a previous study showing an interaction with smoking status, resting heart rate and mortality,[@R23] we performed a subanalysis stratifying the population according to smoking status. A two-sided probability value of p≤0.05 was a priori taken as significant.

Results {#s3}
=======

A total of 2798 subjects were included in the current study; 1082 men (38.7%) died during the 16 years of follow-up.

[Table 1](#HEARTJNL2012303375TB1){ref-type="table"} shows baseline characteristics according to categories of resting heart rate. As shown, high resting heart rate was associated with lower physical fitness, and higher BP, total cholesterol, TGs and BMI. There was no difference in age or social class. Interestingly, subjects in the lowest resting heart rate categories were more likely to be smokers than in the higher resting heart rate categories.

###### 

Demographics

                                        Heart rate (bpm)                                                                              
  ------------------------------------- ------------------ -------------- -------------- -------------- -------------- -------------- ---------
  Resting heart rate (bpm)              47.2 (2.8)         56.0 (2.8)     65.0 (2.9)     74.2 (2.7)     84.7 (2.8)     100.6 (10.3)   
  Lifestyle factors 1985--1986                                                                                                        
   Leisure-time physical activity (%)                                                                                                 
    Low                                 8.6                7.2            9.5            9.0            12.3           11.1           \<0.001
    Medium                              30.9               33.9           38.0           41.8           52.1           55.6           
    High                                60.5               58.9           52.5           52.5           35.6           33.3           
   Smoking (%)                          71.9               58.8           52.8           49.9           42.1           42.6           \<0.001
   Pack-years                           32.3 (23.1)        28.5 (25.3)    27.0 (26.2)    26.4 (23.3)    24.2 (23.0)    25.5 (23.1)    \<0.001
   Alcohol, beverages/week              15.0 (13.5)        15.5 (12.9)    16.0 (13.5)    15.5 (13.2)    16.9 (16.2)    16.7 (16.3)    0.20
  Clinical and metabolic risk factors                                                                                                 
   Systolic BP                          114.9 (17.8)       117.7 (16.5)   120.6 (15.3)   125.3 (16.8)   130.8 (16.6)   132.7 (22.9)   \<0.001
   Systolic BP \>130 (%)                20.3               20.9           26.6           35.9           53.4           48.1           \<0.001
   Diastolic BP                         65.7 (10.5)        70.7 (10.8)    72.9 (10.9)    77.0 (12.9)    78.2 (11.6)    78.9 (11.7)    \<0.001
   Diastolic BP \>85 (%)                5.4                9.5            12.2           20.5           28.8           31.5           \<0.001
   Hypertension (%)†                    13.2               12.3           9.3            10.6           12.5           16.7           0.19
   TG (mmol/l)                          1.36 (0.67)        1.47 (0.87)    1.51 (0.80)    1.69 (1.54)    1.84 (1.69)    1.68 (1.08)    \<0.001
   TG (\>1.70 mmol/l)                   21.4               25.5           27.4           30.3           35.2           26.4           0.002
   HDL-C (mmol/l)                       1.34 (0.32)        1.36 (0.35)    1.37 (0.35)    1.35 (0.35)    1.39 (0.39)    1.48 (0.44)    0.09
   HDL-C (\<1.03 mmol/l)                17.1               16.5           14.5           14.1           17.8           14.8           0.28
   Total cholesterol, mmol/l            6.36 (0.95)        6.47 (1.11)    6.55 (1.10)    6.53 (1.09)    6.53 (1.01)    6.67 (1.11)    0.02
   LDL-C (mmol/l)                       4.75 (0.96)        4.82 (1.09)    4.88 (1.08)    4.84 (1.05)    4.80 (0.99)    4.87 (1.11)    0.36
   BMI (kg/m^2^)                        25.0 (3.0)         25.4 (3.2)     25.7 (3.3)     26.0 (3.8)     26.2 (3.6)     26.6 (3.7)     \<0.001
  Other characteristics                                                                                                               
   Low social class (%)                 48.6               51.5           48.1           48.3           59.6           62.3           0.71
   Age (years)                          62.8 (5.1)         62.4 (4.9)     62.6 (5.3)     62.7 (5.2)     63.9 (5.6)     63.3 (4.8)     0.03

Lifestyle and other characteristics according to resting heart rate group. Values presented are mean (SD) or frequency in per cent.

\*p Values of trend test (Kendall\'s τ B) or test for linearity in analysis of variance.

†Defined as treatment due to hypertension.

BMI, body mass index; BP, blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; TG, triglycerides.

Resting heart rate and physical fitness (VO~2~Max) {#s3a}
--------------------------------------------------

There was a highly significant correlation between VO~2~Max and resting heart rate (R=−0.34, p\<0.001) ([figure 2](#HEARTJNL2012303375F2){ref-type="fig"}). Subjects with higher levels of physical fitness were more likely to have lower resting heart rates.

![Relationship between physical fitness (VO~2~Max) and resting heart rate (bpm).](heartjnl-2012-303375f02){#HEARTJNL2012303375F2}

Resting heart rate and mortality {#s3b}
--------------------------------

Overall, a high resting heart rate was a significant predictor of mortality. As shown in [table 2](#HEARTJNL2012303375TB2){ref-type="table"}, subjects with elevated resting heart rate were at significantly greater risk of mortality in all models (1--5). In the fully adjusted model, resting heart rate in the range 51--80 bpm was associated with about a 40--50% increase in risk, a resting heart rate in the range 81--90 bpm conferred a twofold increase in risk, and resting heart rates above 90 bpm risk conferred a threefold increase in risk compared to subjects in the lowest heart rate category (\<50 bpm).

###### 

HRs (95% confidence limits) for all-cause mortality according levels of resting heart rate

                                        Heart rate (bpm)                                                                                           
  ------------------------------------- ------------------ --------------------- --------------------- --------------------- --------------------- ---------------------
  Crude incidence (%)                   30.5               36.6                  38.1                  40.6                  54.8                  66.7
  HR, adjustment for                                                                                                                               
   (1) Age                              1\*                1.34 (1.03 to 1.73)   1.40 (1.08 to 1.81)   1.51 (1.13 to 2.00)   2.04 (1.47 to 2.82)   3.00 (2.00 to 4.50)
   (2) Age+VO~2~Max                     1\*                1.27 (0.97 to 1.65)   1.27 (0.98 to 1.66)   1.32 (0.99 to 1.78)   1.75 (1.25 to 2.45)   2.55 (1.68 to 3.86)
   (3) Age+lifestyle†                   1\*                1.45 (1.11 to 1.90)   1.57 (1.20 to 2.05)   1.66 (1.24 to 2.23)   2.44 (1.46 to 2.90)   3.37 (2.23 to 5.09)
   (4) Age+clinical factors‡            1\*                1.40 (1.07 to 1.83)   1.47 (1.13 to 1.92)   1.58 (1.18 to 2.13)   2.06 (1.46 to 1.90)   3.11 (2.05 to 4.73)
   (5) Age+all potential confounders§   1\*                1.40 (1.06 to 1.85)   1.46 (1.10 to 1.93)   1.51 (1.11 to 2.06)   2.04 (1.43 to 2.92)   3.06 (1.97 to 4.75)

Cox proportional hazards regression analyses with forced entry of variables.

\*Reference group.

†Leisure-time physical activity, cumulative tobacco consumption (cigarette equivalents), alcohol intake.

‡Body mass index (BMI), systolic blood pressure (BP), diastolic BP, serum triglycerides (TG), serum total cholesterol.

§Leisure time physical activity, VO~2~Max, cumulative tobacco consumption (cigarette equivalents), alcohol intake, BMI, systolic BP, diastolic BP, high serum TG, total serum cholesterol, social class.

In a fully adjusted model with heart rate as a continuous variable, elevated heart rate was associated with an increased risk of 16% (10--22) per 10 bpm increase in resting heart rate.

There was a borderline significant interaction between resting heart rate, smoking status and mortality (p=0.07). In the fully adjusted model and with resting heart rate as a continuous variable, risk increased with 20% (12--27) in smokers, and 14% (4--24) in non-smokers per 10 bpm increase in resting heart rate.

Discussion {#s4}
==========

In the present study of healthy middle-aged men, the main finding was that resting heart rate was a risk factor for mortality independent of physical fitness (VO~2~Max) and other major potential confounders.

Resting heart rate as a risk factor for mortality has received considerable attention in recent years. However, a concern has been whether elevated resting heart rate is merely a surrogate marker of poor physical fitness, which in turn is associated with poor prognosis. A high level of physical fitness is a strong predictor of longevity[@R11] and is associated with lower heart rate, as also demonstrated in the present study. Level of physical fitness therefore plays a pivotal role in the study of resting heart rate. In a study from the Paris Prospective Study, resting heart rate was predictive of mortality and especially sudden death after adjusting for duration of exercise.[@R24] However, the main body of studies use self-reported levels of physical activity[@R22] [@R25] or, in some cases, include no information.[@R26] In the current study, all subjects underwent a physical exercise test and estimation of VO~2~Max as well as an assessment of leisure-time physical activity; we found that irrespective of level of physical fitness subjects with high resting heart rates fare worse than subjects with lower heart rates. This suggests that a high resting heart rate is not a mere marker of poor physical fitness but is an independent risk factor.

There were more smokers in the low heart rate categories than in the higher heart rate categories. Although the acute effects of smoking are tachycardia and increase in BP, healthy smokers are more likely to have lower BP than non-smokers; this has been shown in numerous studies,[@R27; @R28; @R29] and the same mechanisms may explain the observation in the present study. The possible mechanisms are at least twofold and probably pertinent to heart rate as well: first, it represents a counter-regulatory physiological response to the acute rise in BP and heart rate following smoking; and second, the healthy worker effect probably plays a role---smokers in the present study are healthier, leaner and more fit than non-smokers; they can 'endure' the smoking.

Interestingly, we found a borderline significant interaction between resting heart rate, smoking and mortality, which suggests that high heart rate at any given resting heart rate level is associated with greater risk in smokers than in non-smokers. In a study from the Copenhagen City Heart Study,[@R23] resting heart rate was a stronger predictor of all-cause mortality among smokers than among non-smokers, which is in line with results from the present study. That this relationship can be found in two different large cohorts adds to the evidence that a true relationship may exist and not simply be a random association. Considering that the number of smokers globally is about 1 billion,[@R30] this is yet another argument for preventive measures against tobacco consumption and might have therapeutic implications in terms of heart rate monitoring and perhaps modification in smokers.

Several pathophysiological mechanisms have been proposed to explain the relationship between high resting heart rate and mortality.[@R31] [@R32] Resting heart rate has been found to correlate with longevity in mammals. Levine[@R33] showed that the number of heart beats per lifetime is the same across different mammal species, indicating that basal metabolic effects may explain the effect of high resting heart rate on mortality. Smoking is known to promote inflammatory pathways and induce alterations in metabolism, vessel walls, haemostatics and impaired blood flow[@R34] [@R35]; also, high heart rate may promote the development of atherosclerosis and plaque rupture through increase in cardiac work, decreased artery compliance and increase in arterial wall stress.[@R36] Altogether, these mechanisms could be related to the findings of this study. Studies investigating cause-specific mortality, be it mainly mortality from cardiovascular reasons, cancer or other disease entities, may further elucidate the relationship between elevated resting heart rate and longevity.

Methodological considerations {#s4a}
-----------------------------

Possible study limitations should be considered. Since all subjects were employed and recruited from work places, there may have been a 'healthy worker' effect, resulting in the study population being healthier than would be seen in the general population. Also, there may have been a survivor selection bias. Since resting heart rate and VO~2~Max were measured at different examinations, only subjects who survived to attend both examinations were included in the study. This may have biased the results towards the null hypothesis, making the observed HRs smaller than the true HRs.

Also, physical fitness may have changed between the first and the second examination. However, subjects were free of overt disease and survived to participate in the second examination; this makes it more likely that the subjects were healthier than the background population as a whole; second, all subjects with cardiovascular disease, diabetes or absence of sinus rhythm were excluded, suggesting that no major health-related event would have occurred to change general fitness levels substantially; third, a normal deterioration in general fitness over time would be the same in the entire study population and would therefore not affect the findings; and fourth, the correlation between physical fitness measured at the first examination and resting heart rate measured at the second examination supports that cardiorespiratory physical fitness was in general maintained between the two examinations. This is supported by the finding that the correlation between resting heart rate and physical fitness (r=−0.34) found in the present study was identical with the correlation between resting heart rate and physical fitness measured at the same point in time in a male population in the Tromsø Study.[@R14]

Heart rate shows diurnal variation, which may give some imprecision in the estimate of resting heart rate; however, misclassification of heart rate due to a single assessment would bias the results towards the null hypothesis and can therefore not explain our findings.

Finally, it should be mentioned that since the results presented here are based only on findings among healthy, middle-aged and elderly Caucasian men, our results may not necessarily apply to other population groups.

Conclusion {#s5}
==========

In the present study of 2798 healthy, middle-aged and elderly Caucasian men followed for 16 years, resting heart was a risk factor for mortality independent of physical fitness (VO~2~Max) assessed by a bicycle ergometer, leisure-time physical activity and other conventional risk factors. These results suggest that in healthy subjects, elevated resting heart rate is not merely a marker of poor general fitness but an independent risk factor.
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